Common Shares Purchase Agreement Sample Contracts
COMMON SHARES PURCHASE AGREEMENTCommon Shares Purchase Agreement • May 15th, 2025 • GT Biopharma, Inc. • Pharmaceutical preparations • New York
This COMMON SHARES PURCHASE AGREEMENT is made and entered into as of May 14, 2025 (this “Agreement”), by and between Five Narrow Lane, L.P., a Delaware limited partnership And/or its assignee and Bristol Capital, LLC, a Delaware limited liability company and/or its assignee (each an “Investor” and together, the “Investors”), and GT Biopharma, Inc. a Delaware corporation (the “Company”).
Exhibit 10.12 EXECUTION COPY VISIBLE GENETICS INC. COMMON SHARES PURCHASE AGREEMENT DECEMBER 14, 1999 TO EACH OF THE INVESTORS WHO ARE SIGNATORIES HERETO Ladies and Gentlemen: Visible Genetics Inc., an Ontario corporation (the "COMPANY"), hereby...Common Shares Purchase Agreement • March 13th, 2000 • Visible Genetics Inc • Laboratory analytical instruments • New York
EX-99.1 2 d473322dex991.htm EX-99.1 COMMON SHARES PURCHASE AGREEMENTCommon Shares Purchase Agreement • May 5th, 2020 • Illinois
COMMON SHARE PURCHASE AGREEMENT (the “Agreement”), dated as of October 27, 2017, by and between APTOSE BIOSCIENCES INC., a corporation organized under the laws of Canada (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON SHARES PURCHASE AGREEMENTCommon Shares Purchase Agreement • December 16th, 2013 • LNB Bancorp Inc • State commercial banks • Ohio
THIS COMMON SHARES PURCHASE AGREEMENT (this “Agreement”), dated as of December 12, 2013, by and among LNB Bancorp, Inc., an Ohio corporation (the “Company”), and those Persons (as defined below) identified on Schedule 1 hereto (each individually, an “Investor” and collectively, the “Investors”).
APTOSE BIOSCIENCES INC. Common SharesCommon Shares Purchase Agreement • August 2nd, 2019
This prospectus is a part of a registration statement that we have filed with the SEC utilizing a “shelf” registration process. Under this shelf registration process, we may sell any combination of the securities described in this prospectus, either individually or in units, in one or more offerings up to an aggregate initial offering price of $100,000,000.
FIRST AMENDMENT TO COMMON SHARES PURCHASE AGREEMENTCommon Shares Purchase Agreement • June 11th, 2025 • GT Biopharma, Inc. • Pharmaceutical preparations
THIS FIRST AMENDMENT TO COMMON SHARES PURCHASE AGREEMENT (this “Amendment”), dated as of June 10, 2025, by and between Five Narrow Lane, L.P., a Delaware limited partnership And/or its assignee and Bristol Capital, LLC, a Delaware limited liability company and/or its assignee (each an “Investor” and together, the “Investors”), and GT Biopharma, Inc. a Delaware corporation (the “Company”). Capitalized terms used herein and not otherwise defined shall have the meanings ascribed thereto in the Purchase Agreement (as defined below).
COMMON SHARES PURCHASE AGREEMENTCommon Shares Purchase Agreement • October 21st, 2025 • Dih Holding Us, Inc. • Surgical & medical instruments & apparatus • New York
This COMMON SHARES PURCHASE AGREEMENT is made and entered into as of October 15, 2025 (this “Agreement”), by and between Five Narrow Lane, L.P. (the “Investor”), and DIH Holding US, Inc., a Delaware corporation (the “Company”).
COMMON SHARES PURCHASE AGREEMENTCommon Shares Purchase Agreement • November 22nd, 2024 • LandBridge Co LLC • Oil royalty traders • Delaware
it being understood that we express no opinion in clause (b) of this paragraph with respect to any federal or state securities, blue sky or anti-fraud laws, rules or regulations.
●] Common Shares Purchase AgreementCommon Shares Purchase Agreement • September 6th, 2012 • New York
InRetail Perú Corp., a Panamanian corporation (the “Company”), and the shareholders of the Company named in Schedule 2 hereto (the “Selling Shareholders”), propose to sell to the several initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as representatives (the “Representatives”), an aggregate of [●] common shares (the “Underwritten Shares”), with no par value per share, of the Company (the “Common Shares”). In addition, the Company proposes to issue and sell, at the option of the Initial Purchasers, exercisable on or before the thirtieth day following the date of this Agreement, by written notice from the Representatives to the Company, up to an additional [●] Common Shares solely for the purpose of covering over-allotments, if any (the “Option Shares” and, together with the Underwritten Shares, the “Shares”).
COMMON SHARES PURCHASE WARRANT SIDUS SPACE, INC.Common Shares Purchase Agreement • December 19th, 2024 • Sidus Space Inc. • Radiotelephone communications
THIS WARRANT TO PURCHASE COMMON SHARES (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after December 18, 2024 (the “Initial Exercise Date”) and prior to at 5:00 p.m. (New York time) on the date that is five and one-half (5-1/2) years following the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Sidus Space, Inc., a Delaware corporation (the “Company”), up to ______ Common Shares, without par value per share, of the Company (the “Warrant Shares”), as subject to adjustment hereunder. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).